University College London in partnership with National institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre has located translational research projects and spin-outs at its laboratories in SBC. These projects have high commercialization potential and cover a broad range of technologies in drug discovery and medical devices. UCL is driven to engage more closely with the biotechnology and pharmaceutical industries in SBC’s open innovation environment for developing therapeutic solutions to improve patients’ health and quality of life.

Follow @ucl

If you’re a final-year undergraduate, the 2020 National Student Survey is a great opportunity to give feedback on your academic experience. The survey takes around 10 minutes to complete and all responses and comments are anonymous: ucl.ac.uk/you-shape-ucl/… pic.twitter.com/jprnZTtvNa

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.